Jesse K Mckenney, MD
Pathology · Cleveland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Cleveland Clinic · 6,954 clinicians in this group
Hospitals listed: Cleveland Clinic · Cleveland Clinic Avon Hospital · Fairview Hospital · Hillcrest Hospital · Medina Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Mckenney’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A81354 · Cancelled
Licence status: Cancelled · since 2002 · University of Texas Southwestern Medical School at Dallas.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Cleveland ClinicCleveland, OHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Cleveland Clinic, which runs 21 hospitals in 2 statesHome of Case Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.51 (1.39 to 1.62), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 2.7 (2.44 to 2.96) · 20,161 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.6 (11.3 to 14.1) · 2,120 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 6.46 (4.79 to 8.13) · 7,167 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 3.77 (2.46 to 5.08) · 7,190 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.299, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.649, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.477, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 4.1 (3.4 to 5) · 2,120 cases, Jan 2024 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 0.9) · 4,396 cases, Jan 2024 – Dec 2024
- Cleveland Clinic Avon HospitalAvon, OHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Cleveland Clinic, which runs 21 hospitals in 2 statesPatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.526, Oct 2024 – Sep 2025
- Fairview HospitalCleveland, OHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Cleveland Clinic, which runs 21 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.73 (0.49 to 0.97), Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 2.41 (0 to 5.1) · 845 cases, Jul 2022 – Jun 2024Better than the national rate — Pressure ulcer rate: 0.09 (0 to 0.59) · 7,214 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.358, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.396, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.471, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.6 to 1) · 832 cases, Jan 2024 – Dec 2024
- Hillcrest HospitalMayfield Heights, OHAcute Care Hospital · Voluntary non-profit - Private · No emergency department · Birthing-friendlyPart of Cleveland Clinic, which runs 21 hospitals in 2 statesPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.59 (0.35 to 0.84), Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 3.79 (0 to 8.86) · 958 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.18, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.4, Oct 2024 – Sep 2025Better than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 3.4 (2.3 to 4.9) · 377 cases, Jan 2024 – Dec 2024
- Medina HospitalMedina, OHAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Cleveland Clinic, which runs 21 hospitals in 2 statesPatients rate it 3 of 5 · 66% would definitely recommend itOverall rating: 5 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Cleveland Clinic
Behind the star rating — Deaths: 6 better, 2 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 4 better, 4 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.51 (1.39 to 1.62) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 2.7 (2.44 to 2.96) · 20,161 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (11.3 to 14.1) · 2,120 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.46 (4.79 to 8.13) · 7,167 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.77 (2.46 to 5.08) · 7,190 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.299 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.649 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.477 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.1 (3.4 to 5) · 2,120 cases | Better | Jan 2024 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 0.9) · 4,396 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0.29 to 1.3) · 6,469 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.75 (143.33 to 200.18) · 527 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 389 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.3 · 283 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7 · 981 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.6 · 312 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.9 · 438 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2 · 9,668 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0.01 to 0.29) · 19,048 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.13 to 0.42) · 23,325 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.41 (3.44 to 5.38) · 10,735 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.79 (1.2 to 2.38) · 7,312 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (2.23 to 3.76) · 8,769 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.12 (1.11 to 3.13) · 2,849 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 328 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.75 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.615 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.966 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 811 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 1,840 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 25.3 · 442 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12 · 1,224 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44 · 375 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 618 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 343 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.6 · 447 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 392 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (11 to 14.4) · 14,847 cases | No different | Jan 2022 – Dec 2024 |
What patients said (7,072 patients answered, 25% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Cleveland Clinic Avon Hospital
Behind the star rating — Deaths: 3 better, 3 the same, 0 worse of 6 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.526 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.89 (0 to 1.89) · 789 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.52 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.9 · 465 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.5 · 478 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.2 · 145 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,510 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,724 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.09 (0.77 to 5.41) · 512 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.32) · 112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.13 (0.47 to 3.78) · 447 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.08 (0 to 15.92) · 113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.87 (0.68 to 9.05) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.16 to 3.1) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.66 (0 to 1.41) · 3,702 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.383 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.313 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 750 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -15.3 · 518 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -21.5 · 496 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 765 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.8 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.5 · 221 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.2 (9.6 to 15.6) · 1,729 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 703 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,122 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 81% |
| Staff "always" explained new medications | 81% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 65% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for Fairview Hospital
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.73 (0.49 to 0.97) | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.41 (0 to 5.1) · 845 cases | Better | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.09 (0 to 0.59) · 7,214 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.358 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.471 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 832 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.86 (0.07 to 1.65) · 1,824 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 172.39 (124.06 to 220.71) · 97 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.5 · 215 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.5 · 265 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.6 · 621 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.2 · 529 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 368 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.2 · 4,756 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0.02 to 0.38) · 8,073 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.11 to 0.48) · 8,437 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.2 (2.41 to 5.98) · 2,050 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0.27 to 3.02) · 902 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.79 to 3.42) · 1,921 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.31 (3.43 to 13.2) · 858 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 619 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 1.028 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.529 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 482 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 1,250 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 4.7 · 317 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.9 · 725 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 8.1 · 556 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 1,068 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.3 (3 to 6.1) · 301 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.5 (9 to 14.5) · 301 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 559 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 19.5) · 216 cases | No different | Jan 2022 – Dec 2024 |
What patients said (2,166 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Hillcrest Hospital
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 5 better, 2 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.59 (0.35 to 0.84) | Better | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 3.79 (0 to 8.86) · 958 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.18 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.4 | Better | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 3.4 (2.3 to 4.9) · 377 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.94 (0.11 to 1.77) · 2,481 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 158.94 (109.05 to 208.84) · 93 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.5 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 204 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 325 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.1 · 917 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.1 · 860 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 421 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.3 · 6,421 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 11,381 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.06 to 0.42) · 11,562 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.86 (1.12 to 4.6) · 2,493 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1 (0 to 2.34) · 939 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.54 (0.22 to 2.86) · 2,293 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.22 (1.28 to 7.16) · 930 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.41 (0.04 to 2.78) · 659 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.18 (0 to 0.67) · 10,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3 · 137 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.655 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.625 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.091 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 587 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 1,482 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 12.3 · 361 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 16.4 · 1,042 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.7 · 909 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.4 · 1,400 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.4 (9.8 to 15.3) · 377 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 146 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 156 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 450 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.5 to 17.4) · 839 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,407 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,161 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Medina Hospital
Behind the star rating — Deaths: 3 better, 4 the same, 0 worse of 7 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 688 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.63 to 1.41) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.07 (103.75 to 230.39) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.3 · 130 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 352 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.6 · 511 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 2,699 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 4,290 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,302 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.32 (1.99 to 6.65) · 588 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 129 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.37 (0.74 to 4.01) · 542 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.44 (1.06 to 19.82) · 133 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.91 (1.66 to 10.16) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 106 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.47 (0 to 1.25) · 3,628 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 70 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.594 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.268 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.748 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 2.095 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.451 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 26 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 686 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 13.6 · 410 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -16 · 527 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 925 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 82 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 308 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9 to 16.3) · 354 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 439 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,123 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 66% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$38,636
Medicare paid this office $38,636 for 374 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 78 | $10,000 | $127 |
| Pathology examination of tissue using a microscope, moderately high complexity | 90 | $7,444 | $59 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 78 | $5,773 | $72 |
| Pathology examination of tissue using a microscope, high complexity | 30 | $3,201 | $100 |
| Pathology examination of tissue using a microscope, intermediate complexity | 77 | $2,719 | $27 |
See all 13 services
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 78 | $10,000 | $127 |
| Pathology examination of tissue using a microscope, moderately high complexity | 90 | $7,444 | $59 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 78 | $5,773 | $72 |
| Pathology examination of tissue using a microscope, high complexity | 30 | $3,201 | $100 |
| Pathology examination of tissue using a microscope, intermediate complexity | 77 | $2,719 | $27 |
| Special stained specimen slides to examine tissue, each additional procedure | 21 | $2,716 | $32 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 30 | $1,728 | $58 |
| Special stained specimen slides to examine tissue, initial procedure | 23 | $1,029 | $41 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 13 | $953 | $68 |
| Special stained specimen slides to examine tissue, each additional procedure | 11 | $840 | $20 |
| Special stained specimen slides to examine tissue, initial procedure | 14 | $434 | $26 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 12 | $392 | $23 |
| Pathology examination of tissue using a microscope, limited examination | 18 | $60 | $3 |
Who their Medicare patients are
374 Original Medicare patients in 2024. Average age 74 · Women 21% · Also on Medicaid 4% · Health risk score 1.37. At or below the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 75% · Cancer 57% · Chronic kidney disease 34% · Coronary heart disease 33% · Diabetes 29% · Atrial fibrillation 21% · Depression 21% · Heart failure 15% · COPD 15% · Stroke 7% · Dementia 4%.
The office billed $317,572, Medicare allowed $49,551 and paid $38,636; for 713 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 374 | 713 | 74 | 1.37 | $317,572 | $38,636 |
| 2023 | 365 | 685 | 73 | 1.24 | $329,840 | $37,607 |
| 2022 | 450 | 829 | 74 | 1.31 | $300,715 | $42,654 |
| 2021 | 519 | 937 | 73 | 1.42 | $371,058 | $55,805 |
| 2020 | 502 | 958 | 72 | 1.36 | $347,637 | $54,576 |
| 2019 | 554 | 1,009 | 72 | 1.27 | $377,117 | $61,108 |
| 2018 | 511 | 1,065 | 72 | 1.45 | $384,037 | $60,728 |
| 2017 | 528 | 1,058 | 72 | 1.40 | $365,697 | $61,124 |
| 2016 | 489 | 964 | 72 | 1.31 | $319,422 | $48,081 |
| 2015 | 446 | 943 | 70 | 1.55 | $273,179 | $39,969 |
| 2014 | 462 | 1,145 | 71 | 1.34 | $276,426 | $43,915 |
| 2013 | 351 | 1,067 | 71 | 1.24 | $263,825 | $41,345 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 106 | $12,733 | $120 |
| Pathology examination of tissue using a microscope, moderately high complexity | 102 | $7,971 | $61 |
| Pathology examination of tissue using a microscope, intermediate complexity | 98 | $5,090 | $28 |
| Pathology examination of tissue using a microscope, high complexity | 37 | $4,014 | $108 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 35 | $2,159 | $62 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 22 | $1,474 | $67 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 19 | $690 | $28 |
2022: 12 services
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 70 | $8,860 | $127 |
| Pathology examination of tissue using a microscope, moderately high complexity | 90 | $8,143 | $63 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 97 | $7,203 | $74 |
| Pathology examination of tissue using a microscope, intermediate complexity | 99 | $4,719 | $28 |
| Pathology examination of tissue using a microscope, high complexity | 30 | $3,448 | $111 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 47 | $2,882 | $61 |
| Special stained specimen slides to examine tissue, each additional procedure | 27 | $1,770 | $22 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 20 | $1,339 | $67 |
| Special stained specimen slides to examine tissue, each additional procedure | 16 | $974 | $22 |
| Special stained specimen slides to examine tissue, initial procedure | 32 | $853 | $27 |
| Special stained specimen slides to examine tissue, initial procedure | 17 | $455 | $27 |
| Pathology examination of tissue using a microscope, limited examination | 26 | $90 | $3 |
2021: 13 services
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 124 | $16,519 | $133 |
| Pathology examination of tissue using a microscope, moderately high complexity | 106 | $9,357 | $65 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 97 | $7,525 | $76 |
| Pathology examination of tissue using a microscope, intermediate complexity | 121 | $6,411 | $29 |
| Pathology examination of tissue using a microscope, high complexity | 33 | $4,231 | $114 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 55 | $3,461 | $62 |
| Special stained specimen slides to examine tissue, each additional procedure | 19 | $1,878 | $36 |
| Special stained specimen slides to examine tissue, initial procedure | 29 | $1,160 | $37 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 12 | $862 | $66 |
| Special stained specimen slides to examine tissue, each additional procedure | 16 | $714 | $22 |
| Special stained specimen slides to examine tissue, initial procedure | 23 | $660 | $27 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 18 | $650 | $28 |
| Pathology examination of tissue using a microscope, limited examination | 21 | $69 | $3 |
2020: 14 services
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 94 | $13,165 | $140 |
| Pathology examination of tissue using a microscope, moderately high complexity | 105 | $9,012 | $66 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 104 | $8,280 | $78 |
| Pathology examination of tissue using a microscope, intermediate complexity | 129 | $7,609 | $29 |
| Pathology examination of tissue using a microscope, high complexity | 31 | $3,883 | $118 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 54 | $3,646 | $65 |
| Special stained specimen slides to examine tissue, each additional procedure | 26 | $2,829 | $34 |
| Special stained specimen slides to examine tissue, initial procedure | 33 | $1,456 | $42 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 18 | $1,251 | $70 |
| Special stained specimen slides to examine tissue, each additional procedure | 18 | $864 | $23 |
| Special stained specimen slides to examine tissue, initial procedure | 23 | $682 | $28 |
| Pathology examination of specimen during surgery, first tissue block | 11 | $653 | $50 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 12 | $437 | $31 |
| Pathology examination of tissue using a microscope, limited examination | 16 | $62 | $4 |
2019: 14 services
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 111 | $16,205 | $143 |
| Pathology examination of tissue using a microscope, moderately high complexity | 105 | $8,776 | $65 |
| Pathology examination of tissue using a microscope, high complexity | 52 | $7,036 | $117 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 81 | $6,422 | $79 |
| Pathology examination of tissue using a microscope, intermediate complexity | 117 | $5,803 | $30 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 86 | $5,532 | $64 |
| Pathology examination of specimen during surgery, first tissue block | 30 | $2,699 | $50 |
| Special stained specimen slides to examine tissue, each additional procedure | 22 | $2,690 | $35 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 19 | $1,472 | $74 |
| Special stained specimen slides to examine tissue, initial procedure | 27 | $1,146 | $41 |
| Special stained specimen slides to examine tissue, each additional procedure | 14 | $1,070 | $23 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 16 | $723 | $31 |
| Special stained specimen slides to examine tissue, initial procedure | 17 | $520 | $29 |
| Pathology examination of tissue using a microscope, limited examination | 25 | $95 | $3 |
2018: 16 services
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 114 | $16,203 | $141 |
| Pathology examination of tissue using a microscope, moderately high complexity | 115 | $10,239 | $66 |
| Pathology examination of tissue using a microscope, intermediate complexity | 139 | $7,258 | $30 |
| Pathology examination of tissue using a microscope, high complexity | 50 | $6,175 | $119 |
| Pathology examination of specimen during surgery, first tissue block | 34 | $4,666 | $51 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 52 | $4,297 | $80 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 60 | $3,983 | $65 |
| Special stained specimen slides to examine tissue, each additional procedure | 19 | $1,902 | $28 |
| Special stained specimen slides to examine tissue, each additional procedure | 19 | $1,323 | $23 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 16 | $1,217 | $72 |
| Special stained specimen slides to examine tissue, initial procedure | 21 | $867 | $39 |
| Special stained specimen slides to examine tissue, initial procedure | 25 | $725 | $28 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 13 | $407 | $31 |
| Pathology examination of tissue using a microscope, moderately low complexity | 13 | $140 | $9 |
| Pathology examination of tissue using a microscope, limited examination | 24 | $86 | $4 |
| Pathology examination of tissue using a microscope | 12 | $75 | $6 |
2017: 15 services
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 119 | $16,757 | $141 |
| Pathology examination of tissue using a microscope, moderately high complexity | 107 | $9,839 | $66 |
| Pathology examination of tissue using a microscope, intermediate complexity | 127 | $6,582 | $30 |
| Pathology examination of specimen during surgery, first tissue block | 43 | $5,084 | $50 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 57 | $4,682 | $79 |
| Pathology examination of tissue using a microscope, high complexity | 36 | $4,656 | $116 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 62 | $4,116 | $66 |
| Special stained specimen slides to examine tissue, each additional procedure | 23 | $3,644 | $39 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 18 | $1,397 | $78 |
| Special stained specimen slides to examine tissue, initial procedure | 28 | $1,236 | $43 |
| Pathology examination of specimen during surgery, each additional tissue block | 11 | $697 | $25 |
| Special stained specimen slides to examine tissue, each additional procedure | 18 | $683 | $23 |
| Special stained specimen slides to examine tissue, initial procedure | 20 | $570 | $29 |
| Pathology examination of tissue using a microscope, moderately low complexity | 13 | $140 | $9 |
| Pathology examination of tissue using a microscope, limited examination | 37 | $132 | $3 |
2016: 15 services
| Pathology examination of tissue using a microscope, moderately high complexity | 118 | $11,387 | $67 |
| Pathology examination of tissue using a microscope, intermediate complexity | 150 | $7,290 | $29 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 58 | $7,010 | $121 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 64 | $4,873 | $76 |
| Pathology examination of tissue using a microscope, high complexity | 30 | $4,150 | $115 |
| Pathology examination of specimen during surgery, first tissue block | 36 | $4,096 | $49 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 56 | $3,633 | $64 |
| Special stained specimen slides to examine tissue, each additional procedure | 18 | $1,408 | $21 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 12 | $933 | $72 |
| Special stained specimen slides to examine tissue, each additional procedure | 15 | $832 | $21 |
| Special stained specimen slides to examine tissue, initial procedure | 22 | $626 | $28 |
| Special stained specimen slides to examine tissue, initial procedure | 19 | $541 | $28 |
| Pathology examination of specimen during surgery, each additional tissue block | 12 | $393 | $23 |
| Pathology examination of tissue using a microscope, limited examination | 30 | $121 | $4 |
| Pathology examination of tissue using a microscope, moderately low complexity | 13 | $118 | $9 |
2015: 13 services
| Pathology examination of tissue using a microscope, moderately high complexity | 112 | $9,912 | $66 |
| Pathology examination of tissue using a microscope, intermediate complexity | 133 | $8,012 | $30 |
| Pathology examination of tissue using a microscope, high complexity | 34 | $4,637 | $116 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 64 | $4,180 | $64 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 52 | $3,824 | $74 |
| Pathology examination of specimen during surgery, first tissue block | 20 | $2,411 | $49 |
| Special stained specimen slides to examine tissue, each additional procedure | 14 | $1,382 | $24 |
| Special stained specimen slides to examine tissue, initial procedure | 35 | $1,090 | $28 |
| Special stained specimen slides to examine tissue, initial procedure | 23 | $994 | $43 |
| Special stained specimen slides to examine tissue, each additional procedure | 18 | $719 | $17 |
| Pathology examination of tissue using a microscope, moderately low complexity | 53 | $524 | $9 |
| Pathology examination of tissue using a microscope | 19 | $104 | $5 |
| Pathology examination of tissue using a microscope, limited examination | 27 | $100 | $4 |
2014: 10 services
| Pathology examination of tissue using a microscope, intermediate complexity | 177 | $17,942 | $29 |
| Pathology examination of tissue using a microscope, moderately high complexity | 86 | $7,427 | $65 |
| Pathology examination of tissue using a microscope, high complexity | 34 | $4,688 | $114 |
| Pathology examination of specimen during surgery, first tissue block | 49 | $4,415 | $48 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 58 | $3,768 | $65 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 34 | $2,483 | $73 |
| Pathology examination of specimen during surgery, each additional tissue block | 13 | $525 | $24 |
| Pathology examination of tissue using a microscope, moderately low complexity | 38 | $406 | $9 |
| Pathology examination of tissue using a microscope | 26 | $153 | $5 |
| Pathology examination of tissue using a microscope, limited examination | 34 | $122 | $4 |
2013: 8 services
| Pathology examination of tissue using a microscope, intermediate complexity | 165 | $17,670 | $28 |
| Pathology examination of tissue using a microscope, moderately high complexity | 88 | $7,980 | $63 |
| Pathology examination of tissue using a microscope, high complexity | 28 | $3,360 | $112 |
| Pathology examination of specimen during surgery, first tissue block | 44 | $3,110 | $46 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 45 | $2,789 | $61 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 30 | $2,157 | $72 |
| Special stained specimen slides to examine tissue, initial procedure | 25 | $1,797 | $33 |
| Pathology examination of tissue using a microscope, limited examination | 17 | $63 | $3 |
Medicaid work
$1,651 in 2021
Medicaid paid $1,651 for 28 billed services this clinician did in 2021, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 28 | $1,651 |
| 2021 | 28 | 1 | 12 | $1,651 |
Professional record
- NPI
- 1881784379
- Licence
- CA A81354California A81354: Cancelled
- Trained
- University of Texas Southwestern Medical School at Dallas, 1998
- Group
- Cleveland Clinic
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- AR 154802001
- Taxonomy
- Federal specialty code 207ZP0101X (207ZP0101X)
- Mailing address
- 300 Pasteur Dr # L235, Stanford, CA, 94305
- NPI first listed
- 2006-10-13
- NPI last updated
- 2008-06-10
This is when the NPI record was last certified, not a medical board exam.